This inventor holds 6 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC, Msd International Gmbh. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 2,405 
2 out of 73 
1 out of 9 Years Active: 2024-2026
Title: Innovations by Inventor Sebastian Schneider in PRMT5 Inhibitors
Introduction
Sebastian Schneider is a notable inventor based in Boston, MA, who has made significant contributions to the field of medical science through his groundbreaking innovations. With a total of 3 patents to his name, Schneider has developed important compounds aimed at treating serious health conditions such as cancer and genetic blood disorders.
Latest Patents
Sebastian's latest patents focus on PRMT5 inhibitors. Specifically, his inventions provide compounds of Formula (I) and their pharmaceutically acceptable salts, esters, and prodrugs designed to inhibit PRMT5 activity. These compounds are significant in developing pharmaceutical compositions that can be used to treat various conditions, including cancer, sickle cell disease, and hereditary persistence of fetal hemoglobin (HPFH) mutations. The methods of making these compounds and their applications in treatment further validate the potential of his work.
Career Highlights
Throughout his career, Sebastian Schneider has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Merck Sharp & Dohme Corporation and MSD International GmbH. His experience in these leading organizations has contributed to his innovative approaches in the development of new medical treatments.
Collaborations
Collaboration has played a crucial role in Sebastian’s achievements. He has worked alongside talented colleagues, including Shuhei Kawamura and Ryan Quiroz, enhancing the creativity and efficacy of his research and inventions.
Conclusion
In summary, Sebastian Schneider stands out as an inventive force in the pharmaceutical industry with his patented innovations centered around PRMT5 inhibitors. His work not only showcases his ingenuity but also his commitment to improving health outcomes for patients suffering from severe conditions. With ongoing advancements in his research, he continues to be a key figure to watch in the field of medical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile